Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caltag Medsystems is a private UK life science tools company that distributes diagnostic and research reagents and also manufactures cell-stabilisation products for flow cytometry and related laboratory workflows. The company serves research, clinical, and diagnostic customers with a broad catalog spanning antibodies, assays, recombinant proteins, biological samples, DNA/RNA tools, and consumables. Its best-known proprietary product franchise is TransFix, a sample stabilisation reagent used to preserve cellular specimens for downstream analysis. Caltag operates from Buckingham, United Kingdom, holds ISO 13485 certification, and also distributes in vitro diagnostic reagents and human tissue and cell products. The business appears to be primarily a commercial supplier and manufacturer rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caltag Medsystems.